Health Industries
Twitter Updates
Follow @PwCHealth on Twitter to get updates on healthcare issues.
Payers |
Providers |
Pharmaceuticals & Life Sciences |
|---|---|---|
Our featured thinking
- Ready or not: On the road to meaningful use of EHRs and health IT
-
Ready or not: On the road to meaningful use of EHRs and health IT
Only half of hospitals will be ready to apply for the billions of dollars in stimulus funding for EHRs when it becomes available in 2011. Those hospitals that will be ready tend to be those who are working with patients, physicians and insurers on achieving what the government calls "meaningful use."
- Behind the numbers: Medical cost trends 2011
-
Behind the numbers: Medical cost trends 2011
In 2011, a complex set of forces will shape what is projected to be a 9% rise in medical costs for employers. Health reform, coupled with the aftermath of a significant recession, means that medical cost drivers will be more important than ever.
- Health Reform: Prospering in a post-reform world
-
Health Reform: Prospering in a post-reform world
This PricewaterhouseCoopers’ Health Research Institute report illustrates the mega trends that health executives will face as a result of health reform and provides recommendations on prospering in the post-reform world.
- The impact of personalized medicine today
-
The impact of personalized medicine today
Right now in progressive health systems medical researchers and physicians are laboring jointly to bring the practical benefits of personalized medicine to the frontlines of healthcare delivery. Personalized medicine is where genetic testing, health IT, and patient-centered care intersect—and where high-value healthcare will live in the foreseeable future.
- What employers want from health insurers in 2010
-
What employers want from health insurers in 2010
This report addresses how employers’ satisfaction with health insurers has eroded over the past year. Employers’ expectations of their health insurers continue to change. While many studies examine the relationship between employees and their employer-sponsored benefits, less is known about employers and what they want from health insurance carriers.
- Top 10 health industry issues in 2010
-
Top 10 health industry issues in 2010
This year the PricewaterhouseCoopers report suggests that organizations that can effectively leverage relationships, understand the impact of pending reform & potential regulatory changes, and respond to changing consumer demands will be the first emerge from the recession and move forward.
- The new science of personalized medicine: Translating the promise into practice
-
The new science of personalized medicine: Translating the promise into practice
This report, addresses a key new force the industry faces — personalized medicine. This force is redefining the health industry and disrupting the business models of healthcare organizations. Every player in the industry will have to change the way they relate to consumers if they are to compete in an era of personalized medicine.
- Pharma 2020: Taxing Times Ahead — Which Path Will You Take
-
Pharma 2020: Taxing Times Ahead — Which Path Will You Take
Pharma 2020: Taxing times ahead, focuses on the challenges ahead but also shows how companies can adapt their tax planning to support the provision of outcomes-based healthcare and remain competitive.
- Transforming healthcare through secondary use of health data
-
Transforming healthcare through secondary use of health data
This report addresses a key challenge the industry faces — leveraging the vast amount of electronic data which will result from current investments in IT to implement electronic health records. Despite these challenges, the opportunity to cut cost and improve care will drive innovation and collaboration in secondary use of data.
- Reversing course? Life Sciences venture capital investments rise in second quarter, sector captures highest share in MoneyTree™ history
-
Reversing course? Life Sciences venture capital investments rise in second quarter, sector captures highest share in MoneyTree™ history
With venture capital investments in the tech sector down for the first six months of 2009, the life sciences industry offered one of the few bright spots during tough economic times. Reversing Course?, a new report from PricewaterhouseCoopers, looks at how the Life Sciences sector is performing and the factors influencing its success.
- Kelly Barnes
- US health industries leader
- Tel: +1 (214) 754 5172
- Robert Dondero
- US health industries advisory leader
- Tel: +1 (214) 754 7448
Email to a colleague
Print-friendly version